Appendicectomy Versus Antibiotics in the Treatment of Acute Uncomplicated Appendicitis
Information source: Turku University Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Acute Appendicitis
Intervention: Appendicectomy (Procedure); Ertapenem (Drug)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Turku University Hospital Official(s) and/or principal investigator(s): Paulina Salminen, MD, PhD, Principal Investigator, Affiliation: Department of surgery, Turku University Hospital
Summary
Appendicectomy has been the treatment of acute appendicitis for over a hundred years.
Appendicectomy, however, includes operative and postoperative risks despite being a
"routine" operation. At the same time other similar intra-abdominal infections, such as
diverticulitis, are treated with antibiotics. There have been some encouraging reports on
successful treatment of appendicitis with antibiotics and it has been estimated that
operative treatment might be necessary for only 15 - 20 % of patients with acute
appendicitis.
The aim of this randomized prospective study is to compare operative treatment (open
appendicectomy) with conservative treatment with antibiotics (ertapenem, Invanz). Before
randomization acute uncomplicated appendicitis is diagnosed with a CT scan. The hypothesis of
the study is that the majority of patients with uncomplicated acute appendicitis can be
treated successfully with antibiotics and unnecessary appendicectomies can be avoided.
Clinical Details
Official title: Study of Surgical Treatment (Open Appendicectomy) Versus Antibiotic Treatment (Ertapenem) in the Treatment of Acute Uncomplicated Appendicitis
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: The success of antibiotic and surgical treatment in the treatment of acute uncomplicated appendicitis
Secondary outcome: The possible complications, morbidity and mortality of operative and conservative treatmentThe direct and indirect costs of both treatment arms The recurrence of conservatively treated appendicitis
Eligibility
Minimum age: 18 Years.
Maximum age: 60 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age range from 18 to 60 years
- CT scan diagnosed uncomplicated acute appendicitis
Exclusion Criteria:
- Age under 18 years or age over 60 years
- Pregnancy or breast-feeding
- Allergy to contrast media or iodine
- Renal insufficiency
- metformin medication (DM)
- Peritonitis (a perforated appendix)
- Lack of co-operation (unable to give consent)
- A severe other medical condition
- CT-scan: other diagnosis, fecal lithiasis in appendix, perforation, abscess,
suspicion of a tumour
Locations and Contacts
Keski-Suomi Central Hosptal, Jyväskylä, Finland
Mikkeli Central Hospital, Mikkeli, Finland
Oulu University Hospital, Oulu, Finland
Seinäjoki Central Hospital, Seinäjoki, Finland
Tampere University Hospital, Tampere, Finland
Turku University Hospital, Turku, Finland
Additional Information
Related publications: Paajanen H, Grönroos JM, Rautio T, Nordström P, Aarnio M, Rantanen T, Hurme S, Dean K, Jartti A, Mecklin JP, Sand J, Salminen P. A prospective randomized controlled multicenter trial comparing antibiotic therapy with appendectomy in the treatment of uncomplicated acute appendicitis (APPAC trial). BMC Surg. 2013 Feb 8;13:3. doi: 10.1186/1471-2482-13-3.
Starting date: November 2009
Last updated: August 18, 2015
|